0000899243-19-023010.txt : 20190906
0000899243-19-023010.hdr.sgml : 20190906
20190906163023
ACCESSION NUMBER: 0000899243-19-023010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190904
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUFFY MICHAEL P
CENTRAL INDEX KEY: 0001237200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 191079971
MAIL ADDRESS:
STREET 1: C/O POINT THERAPEUTICS INC
STREET 2: 125 SUMMER STREET SUITE 1840
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-04
0
0001521036
Lantheus Holdings, Inc.
LNTH
0001237200
DUFFY MICHAEL P
C/O LANTHEUS HOLDINGS, INC.
331 TREBLE COVE ROAD
NORTH BILLERICA
MA
01862
0
1
0
0
SVP and General Counsel
Common Stock
2019-09-04
4
S
0
5604
20.604
D
138890
D
Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
/s/ Michael P. Duffy
2019-09-06